Los Angeles: AHF Provides Free Meningitis Vaccines to Thousands
LOCATION for AHF’s FREE meningitis vaccinations:
- AHF Hollywood Men’s Wellness Center
1300 N. Vermont Ave., Suite 407, Los Angeles, CA , 90027
Phone: P: (866) 339-2525
Hours: Mon-Wed-Thu-Fri, 5:30pm to 9:00pm Saturday, 9:30am to 5:00pm
The AHF Pharmacy locations will no longer provide the vaccinations
PLEASE NOTE AHF MEN’S WELLNESS CENTER IS CLOSED ON TUESDAYS
FOR INFORMATION ABOUT AHF’s MENINGITIS VACCINE PROGRAM, PLEASE CALL:
- Michael Zimmerman, Program Manager, AHF Hollywood Men’s Wellness Program
- (323) 436-8900 x 5819
- AHF Main Switchboard (323) 860-5200
Meningococcal Meningitis Facts
Vaccine and Disease Information Sheet from the US Centers for Disease Control & Prevention (CDC)
Meningococcal Disease Fact Sheet from Long Beach County Health Alert
Meningococcal Disease FAQ from Long Beach County Health Alert
Informational video: What is Meningococcal Meningitis?
Although the intended audience for this video is college students, the nature of how bacterial Meningococcal Meningitis is spread—as well as the recommendations for vaccination—apply to all high-risk groups including gay men, or men-who-have-sex-with-men (MSM).
AHF’s policy on recommending that those in high-risk groups—including gay men—get vaccinated is based on epidemiologic data released by the U.S. Centers for Disease Control and Prevention (CDC) in a January 10th Morbidity & Mortality Weekly Report (MMWR) that states:
“On September 27, 2012, the New York City (NYC) Department of Health and Mental Hygiene (DOHMH) alerted health-care providers and the public about 12 cases of invasive serogroup C Neisseria meningitidis disease (SCMD) occurring in NYC since August 2010 among men who have sex with men (MSM). Cases were identified through existing mandatory notifiable disease reporting and classified according to the Council of State and Territorial Epidemiologists case definitions. By December 31, 2012, a total of 18 cases had been identified among MSM. For 2012, the incidence rate of invasive meningococcal disease among MSM aged 18-64 years was 12.6 per 100,000 persons, compared with 0.16 among non-MSM males aged 18-64 years. MSM and non-MSM population denominators were obtained from the 2010 NYC Community Health Survey a telephone-based survey of approximately 10,000 NYC residents.”